Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Douglas Jicha

Vascular Surgery Scarborough, ME Medical Doctor

NPI 1306879325 CMS profile 195046

306 US Route 1, Bldg C, Scarborough, ME 04074

Open in the dashboard

General payments

$9,990

65 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Douglas Jicha of Scarborough, ME is reported in the CMS Open Payments database as having received $9,990 across 65 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 68th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $6,666 26
2022 General $1,019 11
2021 General $181 8
2020 General $124 3
2019 General $2,000 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Douglas Jicha
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Douglas Jicha were reported at $0. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Douglas Jicha Vascular Surgery median Middle half National median
2019 $2,000 $796 $226–$2,363 $163
2020 $124 $348 $118–$1,110 $114
2021 $181 $471 $158–$1,421 $132
2022 $1,019 $725 $222–$2,183 $149
2023 $6,666 $836 $257–$2,440 $160
2024 $0 $909 $252–$2,619 $164
2025 $0 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Silk Road Medical, Inc. $7,161 22 payments
  2. W. L. Gore & Associates, Inc. $1,635 10 payments
  3. Cook Medical LLC $401 16 payments
  4. Shockwave Medical, Inc $234 1 payment
  5. Abbott Laboratories $218 3 payments
  6. Bard Peripheral Vascular, Inc. $111 2 payments
  7. Teva Pharmaceuticals USA, Inc. $33 1 payment
  8. Teleflex LLC $27 1 payment
  9. Tactile Systems Technology Inc $24 1 payment
  10. Neurocrine Biosciences, Inc. $24 1 payment
  11. Other $122 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Consulting Fee $4,700 3 payments
  2. Travel and Lodging $3,672 13 payments
  3. Food and Beverage $1,618 49 payments
Products named General payments · program years 2019–2023
  1. ENROUTE Transcarotid Neuroprotection System Cardiology/Vascular Diseases $7,027 20 payments
  2. ENROUTE Transcarotid Stent $7,027 20 payments
  3. EXCLUDER Iliac Branch Endoprosthesis $1,491 7 payments
  4. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter $234 1 payment
  5. Cook Medical Zilver PTX $175 2 payments
  6. ABSOLUTE PRO $165 1 payment
  7. EXCLUDER AAA Endoprosthesis $144 3 payments
  8. ENROUTE Transcarotid Neuroprotection System Carotid Artery Disease $134 2 payments
  9. ENROUTE Transcarotid Stent System $134 2 payments
  10. ENHANCE Transcarotid Peripheral Access Kit $134 2 payments
  11. Other $880 41 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

65 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record